Back to Agenda
[S14] Forefront of Drug Delivery System (DDS) Technology
Session Chair(s)
Mitsuru Hashida, PhD
Program-Specific Professor, Institute for Integrated Cell-Material Sciences
Kyoto University, Japan
The trend of drug development is shifting from small molecules to medium- to high molecules such as peptides, proteins and nucleic acids, but problems such as stability and permeability become major barriers to their practical use. DDS research is becoming active to solve the problem. In this session, pharmaceutical company and research institute introduce the latest research and challenges in developing such DDS technology. In addition, the regulatory authorities introduce the current status and issues of regulation, and the future prospects.
Speaker(s)
Research on Evaluation of Innovative Nanomedicine, a Core Technology for DDS
Kumiko Sakai-Kato, PhD
National Institute of Health Sciences, Japan
Section Head, Division of Drugs
Nano-DDS Resarch in Pharmaceutical Company
Hiroshi Ishihara, PhD
Eisai, Co., Ltd., Japan
Director, Nanomedicine Research
Kosuke Ito, PhD
Kosuke Ito, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Reviewer
Have an account?